Form 4: Imunon Inc. Executive Acquires Stock Options
SEC Filing Form 4
Susan Eylward, General Counsel and Corporate Secretary of Imunon, Inc., acquired stock options on March 14, 2025.
Summary
- Susan Eylward, the General Counsel and Corporate Secretary of Imunon, Inc., filed a Form 4 indicating changes in beneficial ownership.
- On March 14, 2025, Eylward acquired stock options to purchase 6,250 shares of Imunon's common stock at an exercise price of $0.8651 per share.
- The options vest in three tranches: 1/2 on the grant date, 1/4 on the one-year anniversary, and 1/4 on the two-year anniversary of the grant date.
- Following the transaction, Eylward directly owns 6,250 derivative securities.
Sentiment
Score: 5
Explanation: The document is a standard regulatory filing related to stock option grants, which is neutral in sentiment.
Industry Context
Form 4 filings are a routine part of corporate governance, providing transparency into the transactions of company insiders. This filing indicates that a key executive has been granted stock options, which is a common practice for aligning management's interests with those of shareholders.
Stakeholder Impact
- The granting of stock options to a key executive can align management's interests with those of shareholders, potentially incentivizing performance and value creation.
Key Dates
| Date | Description |
|---|---|
| 03/14/2025 | Date of earliest transaction: Stock options acquired |
| 03/14/2025 | Date of grant and first vesting tranche of stock options |
| 03/18/2025 | Date of signature on the Form 4 filing |
| 03/14/2035 | Expiration date of the stock options |
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.